How much does Clinicians Drug Reference make per month?

Based on our ML-calibrated revenue forecast, Clinicians Drug Reference earns approximately $5.0K/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.

Is Clinicians Drug Reference profitable?

With estimated build cost $205K and monthly revenue $5.0K, Clinicians Drug Reference looks slow ROI — payback period is around 3.4 years at the current run-rate. Profitability also depends on paid-acquisition spend and refund rate which the public model doesn't see.

How many users does Clinicians Drug Reference have?

Estimated audience: ~8K lifetime downloads, ~1K monthly active users, and ~220 daily active users. Derived from ratings count × category installs-per-rating × age decay. US-storefront-equivalent — global audience can be 5-10× larger for internationally-distributed apps.

What apps are like Clinicians Drug Reference?

Browse the full Medical category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.

What is Clinicians Drug Reference built with?

Our heuristic places Clinicians Drug Reference on the Native Android (Kotlin) stack (High confidence, 80%). Signals: app bundle size, category context, store-description markers, release-date era. We don't disassemble binaries. Alternative possibilities: Flutter.

Is Clinicians Drug Reference still actively maintained?

Maintenance status: Likely abandoned (95% abandonment risk). Last shipped version was 2+ years ago. The risk score combines time-since-last-update with Editor's Choice / curated featuring + user-base maturity adjustments.

How much would Clinicians Drug Reference sell for?

Estimated acquisition value: $150K (marketplace range $125K – $200K). Calculated as 32× monthly revenue using the standard multiple for the detected monetization model + adjustments for age, rating quality and category demand. Calibrated against 2024-2026 Flippa / Acquire.com / MicroAcquire closed-deal medians.

When was Clinicians Drug Reference last updated?

Clinicians Drug Reference last shipped a new version on 2024-02-08 — more than 2 year(s) ago. This is the date Apple / Google last accepted a new build, not a content-only push.

Who makes Clinicians Drug Reference?

Clinicians Drug Reference is published by MobiSystems on the Google Play Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.

What is Clinicians Drug Reference's BU Score?

Clinicians Drug Reference has a BU Score of 51/100 (Solid). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.

Clinicians Drug Reference

Quality Score

Solid

Clinicians Drug Reference

Name: Clinicians Drug Reference — app revenue, audience, build cost & risk profile
Creator: Bumetric
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Clinicians Drug Reference revenue, Clinicians Drug Reference app analytics, mobile app revenue estimate, Medical revenue, Android app revenue

by MobiSystems

Medium confidence

4.0 Google Play rating

✍️ Bumetric analysis

“

Clinicians Drug Reference is an Android app from MobiSystems in the Medical category, currently rated 4.0★ across 226 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.

Quality Score is 51: Solid (established niche player). For a Medical app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.

Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.

💰 Monthly revenue · now vs forecast

● Right now

$5.0K

per month

→

12-mo forecast

$5.2K – $10.8K

per month

→

24-mo forecast

$6.4K – $19.2K

per month

MID tier

💡 Grow this revenue

Free AI audit of this app’s store listing

Title & subtitle keyword fit
Description hook & conversion structure
Screenshots, ratings, reviews strategy

Run free AI audit →

Typical impact: +2-5× organic installs

📊 Performance Tracking LIVE

1 snapshots on record

idle

Rating

4.0

Reviews

226 reviews

Forecast Revenue / mo

$5.0K

Snapshots tracked

since May 2026

ONE-TIME · BUILD 💰 Estimated build cost

$205K

↳ What it cost to build · not monthly revenue

Likely range $155K – $275K

$25K · MVP floor $100K · indie scale $500K+ · studio build

📈 Pays back in ~3.4y at current MRR

Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.

Where the money goes

🧱 MVP baseline (design + 1-store ship)	+$28K
📱 5 unique screens × $4.5K	+$22K
💎 In-app purchase plumbing	+$9K
⚙ Medical complexity ×1.55	+$32K
🌐 Cross-platform reach (iOS + Android)	+$50K
⚙ 10.2y maintenance × ~1-person team	+$61K

Total estimate $205K

ONE-TIME · EXIT VALUE 💵 Estimated acquisition value

$150K

↳ What it would sell for · not monthly revenue

Marketplace range $125K – $200K · 32× MRR multiple

💸 ~0.7× build cost (under-water)

Synthetic estimate. Multiple band derived from iap / freemium model + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.

How the multiple was built

💎 IAP / freemium model base	28× MRR
📅 10.2y proven track record	+20%
⭐ ★ rating 3.5-4.0 (mixed)	-8%
🏷 Medical category multiple	+12%
⭐ Small user base (<1K ratings)	-8%

Final multiple 32× MRR

👥 Estimated audience size

8.7K

Lifetime downloads (US-equivalent)

Monthly active

1.1K

Daily active

220

Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.

How we sized it

📲 Medical engagement	~55 installs / rating
📅 10.2y of rating accumulation	-30%
🔁 Medical D30 retention	25%
📍 DAU / MAU stickiness	0.20

DAU / MAU 20% sticky

🛠 Estimated tech stack

🤖

Native Android (Kotlin)

High confidence · 80%

Also possible

Flutter

Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.

Signals we read

🏷 Category context	Medical
📦 Compact Android bundle	→ Native Kotlin

💀 Maintenance status

Likely abandoned

95%

Last shipped 2024-02-08 · 958 days ago

0 · Active 50 · At risk 100 · Abandoned

Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.

Risk signals

📅 2y+ since last update	Likely abandoned
👥 Small user base (226 ratings) + 10.2y old	+10% (solo-project pattern)
• 10y old + 1y+ no update	+5% (API deprecation drift)

Verdict Likely abandoned

🔬

How we forecast this revenue

MEDIUM CONFIDENCE

Baseline

$5.0K/mo · ML-estimated from 234 triggers

Growth rate

+4.0% MoM · MID tier baseline (compound monthly)

6 months

$4.7K – $7.9K

12 months

$5.2K – $10.8K

24 months

$6.4K – $19.2K

Compound growth at +4.0% MoM (tier baseline for MID). Range widens with horizon — typical noise band ±25% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.

📊

BU Investment Matrix

Below median · 54/100MID TIERunderperforming peers

Growth Velocity

5.0

Founder Strength

6.9

Product Quality

5.5

Revenue Strength

3.7

Monetization Maturity

5.0

Defensibility

10.0

Market Position

0.0

Operational Safety

7.0

💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
⭐ Quality: 3.95★ across 226 reviews — below category median.
📍 Market: Not yet charting in any of the 9 monitored markets.
📈 Growth: ⚠ last update 955d ago — possibly dormant.
⚠️ Risk: Moderate — dormant (955d since update).

🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.

💵 For acquirers: Estimated asking range 18-32× monthly = $90K-$160K. Portfolio play ($24K/mo combined) commands premium.

Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.

Range:

💰 Forecast Revenue / mo

MODEL

Revenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.

🔬Forecast Breakdown — Why This Estimate?Top 7 of 7 triggers

Our ML model uses 200+ signals from public data. These are the most influential for this app:

premiumREVIEW		+$2,200
5 starREVIEW		+$1,800
Mature app (10y old)METRIC		+$1,500
slowREVIEW		−$1,200
too expensiveREVIEW		−$1,000
Ad-supported / freemiumMETRIC		+$600
Early-stage install base (226 ratings)METRIC		+$400

METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)

📥 Estimated Downloads / week

PROXY · ratings × 50/wk —

Industry-rule estimate (Sensor Tower / data.ai): one weekly install ≈ 50 new ratings. Solid points = tracked snapshots · faded line = pre-tracking model backfill.

📈 Reviews Growth

LIVE

Cumulative review count from first BU snapshot. Each point = a tracked update.

⭐ Rating Trend

LIVE

Average rating evolution. Updates with each new review batch.

🗓️ Snapshot Timeline

HISTORY

Each bar shows a tracked update and the metric delta from the previous snapshot.

Profile & Insights

Everything we know — and don't — about this app and its company.

Identification

App name: Clinicians Drug Reference
Developer: MobiSystems
Bundle ID: com.mobisystems.msdict.embedded.wireless.mcgrawhill.cpdr2016
App Store URL: Open in App Store
Category: Medical
Content rating: Not found
Languages: Not found

Company

Website: www.mobilingo.ai
Tagline: Not found
Description: Not found
Founded: Not found
HQ / Address: Not found
Employees: Not found
Logo: Not found

Revenue

Reported revenue signal / mo: Not found
AI revenue estimate / mo: Not found
AI annual estimate: Not found
Model estimate / mo: $5.0K/mo
Top-grossing rank: Not found
All-time revenue: Not found
Pricing: $9.99 - $19.99 per item

Founder

Founder data not yet collected for this app.

Funding

Funding data not yet collected for this app.

Press & Links

Press & Links data not yet collected for this app.

Contacts & Socials

Contacts & Socials data not yet collected for this app.

Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.

📝 About this app

<b>McGraw-Hill Clinician’s Pocket Drug Reference 2016</b> - Exactly what you need to know about 1400 of the most commonly used medications.

***This is a fully functional 1-day trial version***

Organized alphabetically by generic drug name, Clinician's Pocket Drug Reference zeros-in on must-know information such as selection and administration, mechanisms of action, dosage, cautions, contraindications, and side effects.… View full description on the official store →

App Specs

🔐 Own this app? Claim & verify MRR →

🔖 v14.1.859🔄 updated 2y ago📂 Medical💰 Free📺 Ad-supported💎 IAP $9.99 - $19.99 per item🚀 Launched 2016 (10y old)

🔔

Track this app’s revenue

FREE

Get an email when revenue moves by your threshold. No spam, unsubscribe in one click.

📝 Description

BU Score · Transcendent

Full revenue analysis

Read the article-style breakdown for Clinicians Drug Reference: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.

Read deep-dive →